These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22816532)

  • 1. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis.
    Aslam A; Green RL; Motta L; Ghrew M; Griffiths CE; Warren RB
    Br J Dermatol; 2013 Feb; 168(2):446-7. PubMed ID: 22816532
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated Mycobacterium haemophilum infection in a 72-year-old patient with rheumatoid arthritis on infliximab.
    Collins CS; Terrell C; Mueller P
    BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23505273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Splenic tuberculosis during psoriasis treatment with infliximab].
    Fortaleza GT; Brito Mde F; Santos JB; Figueiredo AR; Gomes P
    An Bras Dermatol; 2009; 84(4):420-4. PubMed ID: 19851677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.
    Tsai TF; Chiu HY; Song M; Chan D
    Br J Dermatol; 2013 Feb; 168(2):444-6. PubMed ID: 22816505
    [No Abstract]   [Full Text] [Related]  

  • 5. Unusual presentation of tuberculosis in an infliximab-treated patient--which is the correct TB screening before starting a biologic?
    Gori A; Fabroni C; Prignano F; Lotti T
    Dermatol Ther; 2010; 23 Suppl 1():S1-3. PubMed ID: 20136915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous tuberculosis revealed by infliximab therapy for presumed sarcoidosis.
    Fraser SJ; Hill AT; McKay DA; Reid WA; Mathers ME; MacDougall G; Schofield OM
    Clin Exp Dermatol; 2010 Jun; 35(4):e141-2. PubMed ID: 19886968
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated cutaneous
    Harder S; Oberholtzer S; Shumilak G; Wudel B
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039354
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis.
    Foulkes AC; Wheeler L; Gosal D; Griffiths CE; Warren RB
    Br J Dermatol; 2014 Jan; 170(1):206-9. PubMed ID: 23909440
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium haemophilum: Cutanoeus nodules in a renal transplant patient.
    Rajpara A; Sri J; Driscoll M
    Dermatol Online J; 2010 Jul; 16(7):3. PubMed ID: 20673531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.
    Wahie S; Alexandroff A; Reynolds NJ
    Clin Exp Dermatol; 2006 May; 31(3):460-1. PubMed ID: 16681606
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of primary varicella infection during infliximab treatment for psoriasis.
    Balato N; Gaudiello F; Balato A; Ayala F
    J Am Acad Dermatol; 2009 Apr; 60(4):709-10. PubMed ID: 19293027
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.
    Kluger N; Girard C; Guillot B; Bessis D
    Acta Derm Venereol; 2009; 89(3):332-4. PubMed ID: 19479148
    [No Abstract]   [Full Text] [Related]  

  • 15. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab.
    Vestergaard C; Deleuran M; Kragballe K
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1272-4. PubMed ID: 17894730
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe neutrophilia induced by infliximab for psoriasis.
    de Oliveira JP; Levy A; Morel P; Guibal F
    Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab for psoriasis.
    Gottlieb AB
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S112-7. PubMed ID: 12894134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticarial vasculitis due do infliximab.
    Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy.
    Eisendle K; Fritsch P
    Br J Dermatol; 2005 Mar; 152(3):585-6. PubMed ID: 15787843
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis.
    Diluvio L; Romiti ML; Angelini F; Campione E; Rossi P; Prinz JC; Chimenti S; Lamioni A
    Br J Dermatol; 2010 Apr; 162(4):895-7. PubMed ID: 20199542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.